BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 24528208)

  • 1. Milestones in understanding platelet production: a historical overview.
    Kuter DJ
    Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Romiplostim: a second-generation thrombopoietin agonist.
    Cohn CS; Bussel JB
    Drugs Today (Barc); 2009 Mar; 45(3):175-88. PubMed ID: 19436840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of thrombopoietin and thrombopoietin receptor agonists.
    Kuter DJ
    Int J Hematol; 2013 Jul; 98(1):10-23. PubMed ID: 23821332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
    Deutsch VR; Tomer A
    Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical use of recombinant human thrombopoietin. Status and perspectives].
    Hansen PB; Hasselbalch HC
    Ugeskr Laeger; 2001 May; 163(19):2659-62. PubMed ID: 11360368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical findings with the first generation of thrombopoietic agents.
    Vadhan-Raj S
    Semin Hematol; 2010 Jul; 47(3):249-57. PubMed ID: 20620436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation.
    Matsuki E; Miyakawa Y; Yamane A; Okamoto S
    Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the potential for thrombopoietic agents in acute leukemia?
    Kuter DJ
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):553-8. PubMed ID: 22127320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin from beginning to end.
    Hitchcock IS; Kaushansky K
    Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion expression and activity assay of a novel fusion protein of thrombopoietin and interleukin-6 in Pichia pastoris.
    Zhiyi H; Wenshan L; Wenze Z; Ning D; Chi Z; Kenan Y; Ping W; Qianqian W; Qing Z
    J Biochem; 2007 Jul; 142(1):17-24. PubMed ID: 17517790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Megakaryopoiesis: regulation of platelet production by thrombopoietin].
    Vainchenker W; Besancenot R; Favale F
    Bull Acad Natl Med; 2013 Feb; 197(2):395-406. PubMed ID: 24919369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
    J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.
    Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T
    Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physiology of platelet production.
    Kuter DJ
    Stem Cells; 1996; 14 Suppl 1():88-101. PubMed ID: 11012207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New thrombopoietic growth factors.
    Kuter DJ
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S347-56. PubMed ID: 19778863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.
    Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K
    Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.